Insulet Corp (PODD)

42.35
NASDAQ : Health Care
Prev Close 42.35
Day Low/High 0.00 / 0.00
52 Wk Low/High 26.50 / 48.23
Avg Volume 519.20K
Exchange NASDAQ
Shares Outstanding 57.65M
Market Cap 2.47B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Insulet Reports Fourth Quarter And Full Year 2016 Financial Results

Insulet Reports Fourth Quarter And Full Year 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results At ATTD In Paris

Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results At ATTD In Paris

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced positive...

Insulet Reaches Analyst Target Price

Insulet Reaches Analyst Target Price

In recent trading, shares of Insulet Corp have crossed above the average analyst 12-month target price of $43.39, changing hands for $43.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Insulet Completes Acquisition Of U.S. Manufacturing Facility In Acton, Massachusetts

Insulet Completes Acquisition Of U.S. Manufacturing Facility In Acton, Massachusetts

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the Company has completed the acquisition...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/13/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 6.09 "days to cover" versus the median component at 5.04. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEUA, APC, CBL, DFRG, EFII, ENR, EPAY, EXTR, HMTV, OCLR, PGEM, PODD, SFLY, TUP Downgrades: CVX, FNFV, OPK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Insulet Corporation To Announce Fourth Quarter And Full Year 2016 Financial Results On February 27, 2017

Insulet Corporation To Announce Fourth Quarter And Full Year 2016 Financial Results On February 27, 2017

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 35 th...

Insulet Celebrates Milestone Of 100,000 Customers Actively Using The Omnipod® System

Insulet Celebrates Milestone Of 100,000 Customers Actively Using The Omnipod® System

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it has reached a...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/14/2016 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 10.73 "days to cover" versus the median component at 6.24. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Here are Friday's top research calls, including upgrades for Express Scripts and Lions Gate, and downgrades for Qorvo and Whole Foods.

Insulet To Webcast Investor Day On November 16, 2016

Insulet To Webcast Investor Day On November 16, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it will host an Investor Day on November...

Insulet Reports Third Quarter 2016 Financial Results

Insulet Reports Third Quarter 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

New Study Shows Majority Of Omnipod® Insulin Management System Users Report Significant Clinical And Quality Of Life Benefits

New Study Shows Majority Of Omnipod® Insulin Management System Users Report Significant Clinical And Quality Of Life Benefits

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the online publication...

Insulet Corporation Honors National Diabetes Awareness Month At The NASDAQ Stock Market Closing Bell Ceremony On November 1st

Insulet Corporation Honors National Diabetes Awareness Month At The NASDAQ Stock Market Closing Bell Ceremony On November 1st

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is kicking off...

Insulet Announces Board And Management Changes

Insulet Announces Board And Management Changes

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced changes to the responsibilities of key...

Insulet Corporation To Announce Third Quarter 2016 Financial Results On November 3, 2016

Insulet Corporation To Announce Third Quarter 2016 Financial Results On November 3, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet Enrolls First Patients In Clinical Trial For Its Omnipod® Artificial Pancreas System

Insulet Enrolls First Patients In Clinical Trial For Its Omnipod® Artificial Pancreas System

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the first...

Insulet Announces Pricing Of Convertible Senior Notes Due 2021

Insulet Announces Pricing Of Convertible Senior Notes Due 2021

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has priced a...

Insulet Announces Private Offering Of Convertible Senior Notes

Insulet Announces Private Offering Of Convertible Senior Notes

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its intention to...

Insulet To Establish Highly-Automated Manufacturing Operation In The United States

Insulet To Establish Highly-Automated Manufacturing Operation In The United States

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced plans to...

Insulet Announces Executive Appointments

Insulet Announces Executive Appointments

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the...

Short Interest Declines 10% For PODD

Short Interest Declines 10% For PODD

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 504,358 share decrease in total short interest for Insulet Corp , to 4,492,960, a decrease of 10.09% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/15/2016 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 9.39 "days to cover" versus the median component at 6.33. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Insider Bets Paying Off At PODD As New 52-Week High Reached

Insider Bets Paying Off At PODD As New 52-Week High Reached

In trading on Thursday, shares of Insulet Corp touched a new 52-week high of $43.48/share. That's a 81.62% rise, or $19.54 per share from the 52-week low of $23.94 set back on 02/12/2016.

Insulet Reports Second Quarter 2016 Financial Results

Insulet Reports Second Quarter 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three...